| 000 | 01860 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516071912.0 | ||
| 264 | 0 | _c20120312 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.1113324109 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, Oliver J | |
| 245 | 0 | 0 |
_aHigh-resolution dose-response screening using droplet-based microfluidics. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cJan 2012 |
||
| 300 |
_a378-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCefsulodin _xpharmacology |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aFluorescence |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aMicrofluidics _xmethods |
| 650 | 0 | 4 |
_aProtein Tyrosine Phosphatase, Non-Receptor Type 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSample Size |
| 650 | 0 | 4 | _aSmall Molecule Libraries |
| 650 | 0 | 4 |
_abeta-Galactosidase _xantagonists & inhibitors |
| 700 | 1 | _aEl Harrak, Abdeslam | |
| 700 | 1 | _aMangeat, Thomas | |
| 700 | 1 | _aBaret, Jean-Christophe | |
| 700 | 1 | _aFrenz, Lucas | |
| 700 | 1 | _aEl Debs, Bachir | |
| 700 | 1 | _aMayot, Estelle | |
| 700 | 1 | _aSamuels, Michael L | |
| 700 | 1 | _aRooney, Eamonn K | |
| 700 | 1 | _aDieu, Pierre | |
| 700 | 1 | _aGalvan, Martin | |
| 700 | 1 | _aLink, Darren R | |
| 700 | 1 | _aGriffiths, Andrew D | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 109 _gno. 2 _gp. 378-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1113324109 _zAvailable from publisher's website |
| 999 |
_c21423340 _d21423340 |
||